文献速递心脑血管急症

MiR-433通过靶向NDRG4经PI3K/Akt通路调控心肌缺血再灌注损伤

MiR-433 Regulates Myocardial Ischemia Reperfusion Injury by Targeting NDRG4 Via the PI3K/Akt Pathway.
PubMed 文献 · Shock · 2020-01-01
一句话结论细胞与大鼠实验显示,抑制miR-433可靶向NDRG4激活PI3K/Akt通路,减轻心肌缺血再灌注损伤。

该研究探讨miR-433在心肌缺血再灌注(IR)损伤中的作用及机制。体外采用H9c2心肌细胞缺氧复氧(HR)模型,转染miR-433 mimic或inhibitor;体内采用大鼠IR模型注射antagomiR-433。结果显示HR后miR-433表达升高,抑制miR-433可提高细胞活力、减少LDH释放和凋亡、下调Bax、上调Bcl-2,并降低IR大鼠血清CK-MB和LDH;双荧光素酶报告基因实验和蛋白印迹提示miR-433直接靶向NDRG4,NDRG4沉默可消除miR-433抑制的保护作用并逆转PI3K/Akt通路激活。结论为miR-433通过靶向NDRG4调控PI3K/Akt信号通路调节心肌IR损伤。

要点

  • H9c2心肌细胞暴露于HR后miR-433表达升高(qRT-PCR)。
  • 转染miR-433 inhibitor可显著提高HR后H9c2细胞活力、减少LDH释放和凋亡、下调Bax、上调Bcl-2。
  • miR-433 mimic显著加重HR诱导的上述损伤效应。
  • 双荧光素酶报告基因实验和蛋白印迹提示miR-433直接靶向NDRG4;NDRG4沉默可消除miR-433抑制对HR损伤的保护作用,并逆转miR-433抑制诱导的PI3K/Akt通路激活。
  • 大鼠IR模型注射antagomiR-433可显著降低血清CK-MB和LDH水平,并升高NDRG4、p-PI3K和p-Akt蛋白表达。

适用人群与场景

  • 体外:H9c2心肌细胞缺氧复氧(HR)模型。
  • 体内:大鼠心肌缺血再灌注(IR)模型。

处置流程与药物剂量

  • 体外:H9c2细胞暴露于HR后分别转染miR-433 mimic和inhibitor。
  • 体内:大鼠IR模型注射antagomiR-433。

研究设计与关键结果

  • qRT-PCR显示H9c2心肌细胞暴露于HR后miR-433表达升高。
  • 转染miR-433 inhibitor显著提高细胞活力、减少LDH释放和凋亡、下调Bax、上调Bcl-2;miR-433 mimic显著加重HR诱导的效应。
  • 双荧光素酶报告基因实验和蛋白印迹提示miR-433直接靶向NDRG4;NDRG4沉默消除miR-433抑制对HR损伤的保护作用,并逆转miR-433抑制诱导的PI3K/Akt通路激活。
  • 大鼠IR模型注射antagomiR-433显著降低血清CK-MB和LDH水平,并升高NDRG4、p-PI3K和p-Akt蛋白表达。

证据类型、等级与局限

  • 证据类型:体外细胞实验与动物实验(非临床研究)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文未据此给出推荐

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Myocardial ischemia reperfusion (IR) injury is a serious issue in the treatment of myocardial infarction. MiR-433 is upregulated in myocardial IR injury, but its specific effects remain unclear. In this study, we explored the effect and mechanism of miR-433 in myocardial IR injury.

METHODS: The expression of miR-433 was measured by qRT-PCR. H9c2 cells were transfected with miR-433 mimic and inhibitor after exposure to HR, respectively. Cell viability was detected by MTT. Cell apoptosis was measured by flow cytometry. Protein expression was assessed by western blot. Dual-luciferase reporter assay was performed to assess the target reaction between miR-433 and NDRG4. In vivo rat model of IR was used, and antagomiR-433 was injected to IR rats.

RESULTS: The qRT-PCR results showed that miR-433 expression increased in H9c2 cardiomyocytes after exposure to HR. Transfection with miR-433 inhibitor significantly increased cell viability, reduced LDH and apoptosis, downregulated Bax level, and upregulated Bcl-2 level. In contrast, the miR-433 mimic significantly augmented the HR-induced effects. Dual-luciferase reporter assay and western blot analysis suggested that miR-433 directly targeted NDRG4. NDRG4 silencing abrogated the protection of miR-433 inhibition on HR injury in H9c2 cells. It also reversed PI3K/Akt pathway activation that was induced by miR-433 inhibition. MiR-433 inhibition significantly decreased CK-MB and LDH serum level in IR rats. And NDRG4, p-PI3K, and p-Akt protein expression was elevated by antagomiR-433 injection in vivo.

CONCLUSION: MiR-433 regulated myocardial IR injury by targeting NDRG4 and modulating PI3K/Akt signal pathway.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Cheng H, Yan W. MiR-433 Regulates Myocardial Ischemia Reperfusion Injury by Targeting NDRG4 Via the PI3K/Akt Pathway. Shock. 2020. PMID: 32187107. doi:10.1097/SHK.0000000000001532

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。